Gallbladder cancer with EGFR mutation and its response to GemOx with erlotinib: a case report and review of literature

BACKGROUND: Gallbladder cancer (GBC) is the most common and aggressive extra hepatic biliary tree cancer (BTC) with dismal outcome. Complete surgical resection is the treatment of choice. Chemotherapy is used for palliation in advanced GBC where surgery is not possible, and the most commonly used ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Soni, Kishan, Kumar, Tarun, Pandey, Manoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335444/
https://www.ncbi.nlm.nih.gov/pubmed/32622356
http://dx.doi.org/10.1186/s12957-020-01934-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335444/
https://www.ncbi.nlm.nih.gov/pubmed/32622356
http://dx.doi.org/10.1186/s12957-020-01934-4

Ejemplares similares